JUDY HSIEH: Open Payments
NPI 1881183713 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 14 payments from 10 companies in 2025. Trend: 2023 $47 · 2024 $312 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 2 | $150 |
| Novartis Pharmaceuticals Corporation | 2 | $64 |
| GENZYME CORPORATION | 2 | $63 |
| Regeneron Healthcare Solutions, Inc. | 1 | $40 |
| ABBVIE INC. | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 1 | $34 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $24 |
| Incyte Corporation | 1 | $24 |
| UCB, Inc. | 1 | $15 |
| Journey Medical Corporation | 1 | $14 |
Products named: Zoryve, DUPIXENT, Rhapsido, SKYRIZI, Sotyktu, Winlevi, OPZELURA, Bimzelx.
Industry payments across CA — which companies pay providers there.
